Rakesh Heer

3.2k total citations
78 papers, 1.6k citations indexed

About

Rakesh Heer is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Rakesh Heer has authored 78 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 33 papers in Pulmonary and Respiratory Medicine and 32 papers in Surgery. Recurrent topics in Rakesh Heer's work include Prostate Cancer Treatment and Research (23 papers), Bladder and Urothelial Cancer Treatments (19 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Rakesh Heer is often cited by papers focused on Prostate Cancer Treatment and Research (23 papers), Bladder and Urothelial Cancer Treatments (19 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Rakesh Heer collaborates with scholars based in United Kingdom, United States and Netherlands. Rakesh Heer's co-authors include Craig Robson, Hing Y. Leung, Rajan Veeratterapillay, Mohammad Moad, Luke Gaughan, C.D.M. Griffith, J Shrimankar, Laura Wilson, Anastasia C. Hepburn and Stuart C. Williamson and has published in prestigious journals such as Cell, Nucleic Acids Research and Nature Communications.

In The Last Decade

Rakesh Heer

71 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rakesh Heer United Kingdom 24 928 519 330 313 286 78 1.6k
Zhong Wu China 23 922 1.0× 370 0.7× 328 1.0× 276 0.9× 439 1.5× 86 1.7k
Vladimir Bilim Japan 25 1.4k 1.5× 475 0.9× 583 1.8× 255 0.8× 397 1.4× 81 2.1k
David J. DeGraff United States 24 981 1.1× 518 1.0× 402 1.2× 789 2.5× 323 1.1× 69 1.8k
Anne E. Kiltie United Kingdom 32 1.3k 1.4× 495 1.0× 571 1.7× 826 2.6× 450 1.6× 78 2.5k
Roman Nawroth Germany 24 985 1.1× 601 1.2× 577 1.7× 321 1.0× 476 1.7× 82 2.1k
Tatsuhiro Yoshiki Japan 21 550 0.6× 314 0.6× 246 0.7× 248 0.8× 245 0.9× 68 1.3k
Motoyoshi Tanaka Japan 22 919 1.0× 244 0.5× 361 1.1× 189 0.6× 258 0.9× 49 1.5k
Mark Linch United Kingdom 23 887 1.0× 492 0.9× 690 2.1× 363 1.2× 202 0.7× 74 1.9k
Isabel Heidegger Austria 26 829 0.9× 1.2k 2.3× 553 1.7× 489 1.6× 554 1.9× 123 2.4k
Shusuke Akamatsu Japan 21 692 0.7× 884 1.7× 279 0.8× 154 0.5× 573 2.0× 156 1.8k

Countries citing papers authored by Rakesh Heer

Since Specialization
Citations

This map shows the geographic impact of Rakesh Heer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rakesh Heer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rakesh Heer more than expected).

Fields of papers citing papers by Rakesh Heer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rakesh Heer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rakesh Heer. The network helps show where Rakesh Heer may publish in the future.

Co-authorship network of co-authors of Rakesh Heer

This figure shows the co-authorship network connecting the top 25 collaborators of Rakesh Heer. A scholar is included among the top collaborators of Rakesh Heer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rakesh Heer. Rakesh Heer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heer, Rakesh, et al.. (2025). Combining Spatial Transcriptomics, Pseudotime, and Machine Learning Enables Discovery of Biomarkers for Prostate Cancer. Cancer Research. 85(13). 2514–2526. 2 indexed citations
2.
Galbraith, Laura C.A., Robin Shaw, Rajan Veeratterapillay, et al.. (2025). Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFos. British Journal of Cancer. 132(6). 502–512.
3.
4.
5.
Singh, Parmveer, Nadia A. Lanman, Laura Wilson, et al.. (2023). Human prostate organoid generation and the identification of prostate development drivers using inductive rodent tissues. Development. 150(13). 1 indexed citations
6.
Clark, Emma, Holly Fisher, Ruth Wood, et al.. (2023). Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial. SHILAP Revista de lepidopterología. 2. 49–49. 4 indexed citations
7.
Scott, Emma, Karen E. Livermore, Huw D. Thomas, et al.. (2023). The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer. Scientific Reports. 13(1). 17031–17031. 7 indexed citations
8.
9.
Sachdeva, Ashwin, Claire A. Hart, Christopher D. Carey, et al.. (2022). Automated quantitative high-throughput multiplex immunofluorescence pipeline to evaluate OXPHOS defects in formalin-fixed human prostate tissue. Scientific Reports. 12(1). 6660–6660. 4 indexed citations
10.
11.
Veeratterapillay, Rajan, Rakesh Heer, Mark Johnson, Raj Persad, & Christian Bach. (2016). High-Risk Non-Muscle-Invasive Bladder Cancer—Therapy Options During Intravesical BCG Shortage. Current Urology Reports. 17(9). 68–68. 57 indexed citations
12.
Widera, Paweł, et al.. (2016). Functional networks inference from rule-based machine learning models. BioData Mining. 9(1). 28–28. 5 indexed citations
13.
Hepburn, Anastasia C., Rajan Veeratterapillay, Stuart C. Williamson, et al.. (2012). Side Population in Human Non-Muscle Invasive Bladder Cancer Enriches for Cancer Stem Cells That Are Maintained by MAPK Signalling. PLoS ONE. 7(11). e50690–e50690. 40 indexed citations
14.
Veeratterapillay, Rajan, et al.. (2012). Can the Kattan nomogram still accurately predict prognosis in renal cell carcinoma using the revised 2010 tumor–nodes–metastasis reclassification?. International Journal of Urology. 19(8). 773–776. 2 indexed citations
15.
Williamson, Stuart C., Anastasia C. Hepburn, Laura Wilson, et al.. (2012). Human α2β1HI CD133+VE Epithelial Prostate Stem Cells Express Low Levels of Active Androgen Receptor. PLoS ONE. 7(11). e48944–e48944. 13 indexed citations
16.
Heer, Rakesh, Matthew J. Jackson, Amira El‐Sherif, & David J. Thomas. (2010). Twenty‐nine Leydig cell tumors: Histological features, outcomes and implications for management. International Journal of Urology. 17(10). 886–889. 15 indexed citations
17.
McCracken, Stuart, Rakesh Heer, Marie E. Mathers, et al.. (2007). Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer. Oncogene. 27(21). 2978–2988. 65 indexed citations
18.
Gommersall, Lyndon, Farhat L. Khanim, D M Peehl, et al.. (2004). Oral Presentations 7. British Journal of Cancer. 91(S1). S20–S21. 1 indexed citations
19.
Heer, Rakesh, et al.. (2004). Fibroblast growth factor 17 is over‐expressed in human prostate cancer. The Journal of Pathology. 204(5). 578–586. 47 indexed citations
20.
Heer, Rakesh, et al.. (2004). A Prospective Audit of Hypospadias Correction in a Regional Paediatric Surgery Centre. European Journal of Pediatric Surgery. 14(5). 328–332. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhong Wu Breakdown of academic impact, for papers by Vladimir Bilim Breakdown of academic impact, for papers by David J. DeGraff Breakdown of academic impact, for papers by Anne E. Kiltie Breakdown of academic impact, for papers by Roman Nawroth Breakdown of academic impact, for papers by Tatsuhiro Yoshiki Breakdown of academic impact, for papers by Motoyoshi Tanaka Breakdown of academic impact, for papers by Mark Linch Breakdown of academic impact, for papers by Isabel Heidegger Breakdown of academic impact, for papers by Shusuke Akamatsu
Rankless by CCL
2026